Compounding For Lower Prices Not PBMs’ New ‘Game Plan,’ Lawmakers Told
Executive Summary
Pharmacy benefit manager trade group chief Mark Merritt says PBMs are not poised to broadly promote compounded drugs as cheaper alternatives to off-patent drugs with no generic competition.